Log In
BCIQ
Print this Print this
 

NAL8812

  Manage Alerts
Collapse Summary General Information
Company NAL Pharmaceuticals Ltd.
DescriptionTransdermal patch for three-day deliver of donepezil
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationAlzheimer's disease (AD)
Indication DetailsTreat Alzheimer's disease (AD)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today